Cargando…
Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care
The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597153/ https://www.ncbi.nlm.nih.gov/pubmed/28970440 http://dx.doi.org/10.3390/pharmacy5020028 |
_version_ | 1783263658165403648 |
---|---|
author | Kjeldsen, Lene Juel Olesen, Charlotte Hansen, Merete Kjær Nielsen, Trine Rune Høgh |
author_facet | Kjeldsen, Lene Juel Olesen, Charlotte Hansen, Merete Kjær Nielsen, Trine Rune Høgh |
author_sort | Kjeldsen, Lene Juel |
collection | PubMed |
description | The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “pharmacist(s)” and “controlled” and “outcome(s)” or “effect(s)”. Primary research studies in English of controlled, clinical pharmacy intervention studies, including outcome evaluation, were selected. Titles, abstracts and full-text papers were assessed individually by two reviewers, and inclusion was determined by consensus. In total, 37 publications were included in the review. The publications presented similar intervention elements but differed in study design. A large variety of outcome measures (135) had been used to evaluate the effect of the interventions; most frequently clinical measures/assessments by physician and health care service use. No apparent pattern was established among primary outcome measures with significant effect in favour of the intervention, but positive effect was most frequently related to studies that included power calculations and sufficient inclusion of patients (73% vs. 25%). This review emphasizes the importance of considering the relevance of outcomes selected to assess clinical pharmacy interventions and the importance of conducting a proper power calculation. |
format | Online Article Text |
id | pubmed-5597153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-55971532017-09-29 Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care Kjeldsen, Lene Juel Olesen, Charlotte Hansen, Merete Kjær Nielsen, Trine Rune Høgh Pharmacy (Basel) Article The objective was to investigate type, frequency and result of clinical outcomes used in studies to assess the effect of clinical pharmacy interventions in inpatient care. The literature search using Pubmed.gov was performed for the period up to 2013 using the search phrases: “Intervention(s)” and “pharmacist(s)” and “controlled” and “outcome(s)” or “effect(s)”. Primary research studies in English of controlled, clinical pharmacy intervention studies, including outcome evaluation, were selected. Titles, abstracts and full-text papers were assessed individually by two reviewers, and inclusion was determined by consensus. In total, 37 publications were included in the review. The publications presented similar intervention elements but differed in study design. A large variety of outcome measures (135) had been used to evaluate the effect of the interventions; most frequently clinical measures/assessments by physician and health care service use. No apparent pattern was established among primary outcome measures with significant effect in favour of the intervention, but positive effect was most frequently related to studies that included power calculations and sufficient inclusion of patients (73% vs. 25%). This review emphasizes the importance of considering the relevance of outcomes selected to assess clinical pharmacy interventions and the importance of conducting a proper power calculation. MDPI 2017-05-20 /pmc/articles/PMC5597153/ /pubmed/28970440 http://dx.doi.org/10.3390/pharmacy5020028 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kjeldsen, Lene Juel Olesen, Charlotte Hansen, Merete Kjær Nielsen, Trine Rune Høgh Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title | Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title_full | Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title_fullStr | Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title_full_unstemmed | Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title_short | Clinical Outcomes Used in Clinical Pharmacy Intervention Studies in Secondary Care |
title_sort | clinical outcomes used in clinical pharmacy intervention studies in secondary care |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597153/ https://www.ncbi.nlm.nih.gov/pubmed/28970440 http://dx.doi.org/10.3390/pharmacy5020028 |
work_keys_str_mv | AT kjeldsenlenejuel clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare AT olesencharlotte clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare AT hansenmeretekjær clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare AT nielsentrinerunehøgh clinicaloutcomesusedinclinicalpharmacyinterventionstudiesinsecondarycare |